| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-05 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-05 |